UP!
| 2016-06-20 | Reiterated Rating | Piper Jaffray | Overweight | $11.00 |
| 2016-06-20 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $11.00 |
| 2016-06-17 | Reiterated Rating | Needham & Company LLC | Buy | $11.00 |
| 2016-06-14 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-06-14 | Reiterated Rating | FBR & Co | Buy | |
| 2016-05-14 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-04-23 | Reiterated Rating | Needham & Company LLC | Buy | |
| 2016-04-19 | Boost Price Target | Roth Capital | Buy | $11.00 to $18.00 |
| 2016-03-30 | Lower Price Target | Stifel Nicolaus | Buy | $16.00 to $10.00 |
| 2016-03-19 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-03-17 | Lower Price Target | FBR & Co. | Outperform | $16.00 to $14.00 |
| 2016-03-09 | Reiterated Rating | FBR & Co. | Outperform | |
| 2016-03-09 | Lower Price Target | JPMorgan Chase & Co. | Market Outperform | $17.00 to $12.00 |
| 2016-03-09 | Lower Price Target | JMP Securities | Market Outperform | $17.00 to $12.00 |
| 2016-03-08 | Lower Price Target | Needham & Company LLC | Buy | $14.00 to $11.00 |
| 2016-03-07 | Reiterated Rating | Piper Jaffray | Buy | $11.00 |
| 2016-01-26 | Reiterated Rating | FBR & Co. | Outperform | $16.00 |
| 2015-11-17 | Reiterated Rating | Piper Jaffray | Overweight | $20.00 to $11.00 |
| 2015-11-17 | Lower Price Target | Needham & Company LLC | Buy | $17.00 to $14.00 |
| 2015-11-16 | Lower Price Target | FBR & Co. | Outperform | $19.00 to $17.00 |
| 2015-10-08 | Reiterated Rating | Roth Capital | Buy | |
| 2015-10-08 | Reiterated Rating | Needham & Company LLC | Buy | $17.00 |
| 2015-08-13 | Reiterated Rating | Roth Capital | Buy | |
| 2015-07-16 | Reiterated Rating | Roth Capital | Buy | |
| 2015-06-26 | Initiated Coverage | FBR & Co. | Outperform | $19.00 |
| 2015-06-09 | Set Price Target | MLV & Co. | Buy | $13.00 |
| 2015-05-18 | Reiterated Rating | Roth Capital | Buy | $21.00 |
| 2015-04-19 | Reiterated Rating | MLV & Co. | Buy | $13.00 |
| 2015-03-31 | Reiterated Rating | MLV & Co. | Buy | $13.00 |
| 2015-03-26 | Initiated Coverage | Roth Capital | Buy | $21.00 |
| 2015-02-25 | Initiated Coverage | MLV & Co. | Buy | $13.00 |
| 2014-08-19 | Initiated Coverage | Stifel Nicolaus | Buy | $16.00 |
| 2014-03-04 | Initiated Coverage | Stifel Nicolaus | Buy to Buy | $16.00 |
| 2014-03-04 | Initiated Coverage | Piper Jaffray | Overweight | $18.00 |
| 2014-03-04 | Initiated Coverage | JMP Securities | Outperform | $17.00 |
| 2014-03-04 | Initiated Coverage | Needham & Company LLC | Buy | $17.00 |
| 2016-06-20 | Reiterated Rating | Piper Jaffray | Overweight | $11.00 |
| 2016-06-20 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $11.00 |
| 2016-06-17 | Reiterated Rating | Needham & Company LLC | Buy | $11.00 |
| 2016-06-14 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-06-14 | Reiterated Rating | FBR & Co | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ARGS 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Pharmstandard International S.A. | 66.87% (13142784) | ARGS / |
| van Deventer Sander | 31.54% (6199961) | ARGS / QURE / |
| MERIX BIOSCIENCE INC | 23.10% (4541100) | ARGS / |
| ForArgos B.V. | 19.08% (3749817) | ARGS / |
| Cooperatieve AAC LS U.A. | 12.47% (2450144) | ARGS / |
| Underdown Brian J. | 6.36% (1249572) | ARGS / VTGN / |
| Abbey Jeffrey D Chief Executive Officer | 0.47% (93337) | ARGS / |
| Van Holle Philippe Marie Marcel Joseph | 0.25% (48692) | ARGS / |
| Winterbottom Joan Chief Human Resources Officer | 0.24% (47248) | ARGS / FOLD / |
| MIESOWICZ FREDERICK COO | 0.19% (36843) | ARGS / |
| Nicolette Charles A. CSO | 0.10% (20056) | ARGS / |
| Mtibelishvily Irackly | 0.08% (14895) | ARGS / |
| Birner Hubert | 0.06% (12680) | ARGS / PRTO / |
| Harrelson Lori R. Vice President of Finance | 0.06% (11776) | ARGS / |
| Katz Richard D VP & Chief Financial Officer | 0.05% (9697) | ARGS / |
| Carey Robert | 0.04% (8206) | ARGS / HZNP / SGMO / |
| ALLEN LEE F MD PhD Chief Medical Officer | 0.04% (7378) | AMAG / ARGS / SPPI / |
| Petrov Andrei Vladimirovich | 0.03% (6660) | ARGS / |
| Krol Igor | 0.02% (3874) | ARGS / |
| Vinogradov Alexey Alexandrovich | 0.02% (3367) | ARGS / |
| Lamarre Jean | 0.01% (2500) | ARGS / |
UM